Figure 8. Met inhibits HCC cell growth in vivo. (A) Image of tumors in each group. (B) Growth curves of the tumors in each group. (C) Tumor weights in the different groups. (D) IHC was used to evaluate the expression of Ki-67, NLRP3, caspase1, IL-1β, and IL-18. *P<0.05, Met vs. control group, Met + si-FOXO3 vs. Met+si-nc group.